CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS

Citation
R. Sangrigoli et Hj. Eisen, CONCURRENT LIPID-LOWERING THERAPY WITH HMG-COA REDUCTASE INHIBITORS REDUCES THE INCIDENCE OF ISHLT GRADES 3A AND 3B REJECTION IN CARDIAC TRANSPLANT RECIPIENTS, Circulation, 96(8), 1997, pp. 2061-2061
Citations number
NO
Categorie Soggetti
Peripheal Vascular Diseas",Hematology
Journal title
ISSN journal
00097322
Volume
96
Issue
8
Year of publication
1997
Supplement
S
Pages
2061 - 2061
Database
ISI
SICI code
0009-7322(1997)96:8<2061:CLTWHR>2.0.ZU;2-H